Table 2.
MR estimates of the causal effect of amyloid on t-tau and p-tau as well as the causal effect of t-tau on amyloid
| Study type | Methods | β | se | 95% CI | P value |
|---|---|---|---|---|---|
| Amyloid SNPs with t-tau | MR Egger | 0.85 | 0.15 | 0.54 to 1.15 | <.001 |
| Weighted median | 0.73 | 0.22 | 0.31 to 1.16 | <.001 | |
| IVW | 0.86 | 0.11 | 0.65 to 1.08 | <.001 | |
| Simple median | 0.81 | 0.50 | −0.17 to 1.80 | .110 | |
| Amyloid SNPs with p-tau | MR Egger | 0.73 | 0.17 | 0.39 to 1.06 | <.001 |
| Weighted median | 0.62 | 0.23 | 0.17 to 1.06 | .006 | |
| IVW | 0.86 | 0.12 | 0.62 to 1.10 | <.001 | |
| Simple median | 1.31 | 0.52 | 0.29 to 2.33 | .014 | |
| t-tau SNPs with amyloid | MR Egger | −0.45 | 0.36 | −1.15 to 0.26 | .23 |
| Weighted median | −0.31 | 0.29 | −0.87 to 0.25 | .27 | |
| IVW | −0.02 | 0.20 | −0.42 to 0.38 | .93 | |
| Simple median | −0.20 | 2.05 | −4.22 to 3.81 | .92 |
Abbreviations: β, β coefficient; CI, confidence interval; IVW, inverse-variance weighted; MR, Mendelian randomization; t-tau, total tau; p-tau, phosphorylated tau; SNP, single nucleotide polymorphism.